BOSTON, April 26, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the...
CLAUDIO-01 is the first-in-human trial of SOT102, a CLDN18.2 (Claudin 18.2) targeting antibody-drug conjugate (ADC)The trial will enroll up to...
Webinar to feature presentations from Harold Bays, MD, and Deepak L. Bhatt, MD, MPH, on Wednesday, May 4th at 11:00...
FDA grants Fast Track designation to facilitate development and expedite the review of therapies with potential to treat serious unmet...
A Phase 1b clinical trial of ONC-392 in PD(L)1-resistant NSCLC is currently underwayROCKVILLE, Md., April 26, 2022 (GLOBE NEWSWIRE) --...
BOSTON, April 26, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...
BATON ROUGE, La., April 26, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal...
Customers report continued workflow advantages and clinical superiority with iCAD’s suite of AI‐powered breast health solutions, compared to other available...
Urges shareholders to vote “FOR” Athira’s highly qualified, independent director nominees – Joseph Edelman, John M. Fluke, Jr. and Grant...
YARDLEY, Pa., April 26, 2022 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose...
DUBLIN, Ireland, April 26, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines...
Fireside chat scheduled for Thursday, April 28, 2022 at 12:30 PM ETNEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- TG...
Rebrand reflects an integrated approach to water safety, with expanded focus on customer solutions and educational resources SOUTH ORANGE, NJ, April...
Enhanced iSpecimen Marketplace Search Interface iSpecimen’s enhanced Marketplace now enables more precise specimen matching through an easy-to-use interface that allows...
SAN CARLOS, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel...
Program for K-12 schools for lab-based testing along with supply and management of rapid tests is extended through the 2022-2023...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
Proven Pharmaceutical Marketing Leader Brings Extensive Experience in Rare Diseases, Digital Innovation and New Product Launches to Relief's U.S. Commercial...
Los Angeles, California--(Newsfile Corp. - April 25, 2022) - B token, Hibiki Finance, has officially acquired rival Binance Smart Chain...
NEW YORK, April 25, 2022 /PRNewswire/ -- TransPerfect, the world's largest provider of language and technology solutions for global business, today...